Pre-exercise with treadmill protects dopaminergic neurons in 6-hydroxydopamine rat model of Parkinson’s disease:possible effects on neuroinflammatory injury

Pre-exercise with treadmill protects dopaminergic neurons in 6-hydroxydopamine rat model of Parkinson’s disease:possible effects on neuroinflammatory injury

碩士 === 國立陽明大學 === 物理治療暨輔助科技學系 === 101 === Background: Parkinson’s disease (PD) is a neurodegenerative, slowly progressive disorder, mainly characterized by the selective loss of dopaminergic neurons of the substantia nigra pars compacta (SNpc). Recent studies suggest that neuroinflammation process a...

Full description

Bibliographic Details
Main Authors:	Ti-Hsuan Chen, 陳滌鍹
Other Authors:	Yea-Ru Yang
Format:	Others
Language:	zh-TW
Published:	2013
Online Access:	http://ndltd.ncl.edu.tw/handle/31319313169980093596

Similar Items

Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways
by: Xiaomei Yang, et al.
Published: (2020-01-01)

Protective effects of DA-9805 on dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity in the models of Parkinson’s disease
by: Hyeyoon Eo, et al.
Published: (2019-09-01)

Modafinil Improves Catalepsy in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease; Possible Involvement of Dopaminergic Neurotransmission
by: Reza Vajdi-Hokmabad, et al.
Published: (2017-09-01)

Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease.
by: Avik Roy, et al.
Published: (2012-01-01)

Protective Effect of the α7 Nicotinic Receptor Agonist PNU-282987 on Dopaminergic Neurons Against 6-Hydroxydopamine, Regulating Anti-neuroinflammatory and the Immune Balance Pathways in Rat
by: Ying Jiang, et al.
Published: (2021-01-01)

Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson’s Disease
by: Zhongyuan Yu, et al.
Published: (2018-09-01)

Neuroprotective Effects on Dopaminergic Neurons during Treadmill Training in 6-OHDA Rat Model of Parkinson’s Disease
by: Zih-Yi Hei, et al.
Published: (2012)

The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats
by: Roberta Oliveira da Costa, et al.
Published: (2017-01-01)

Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease
by: Katrine Fabricius, et al.
Published: (2017-12-01)

Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease
by: Venissa Machado, et al.
Published: (2016-04-01)

Corrigendum to “The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats”
by: Roberta Oliveira da Costa, et al.
Published: (2018-01-01)

Neuroprotective effect of Portulaca oleracea extracts against 6-hydroxydopamine-induced lesion of dopaminergic neurons
by: WALESKA B. MARTINS, et al.
Published: (2016-01-01)

Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease
by: V. Rizelio, et al.
Published: (2010-01-01)

Treadmill training improves motor deficits and mitochondrial function in the unilateral 6-hydroxydopamine rat model of Parkinson’s disease
by: Chieh-Sen Chuang, et al.
Published: (2017)

Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine.
by: Katsuaki Suzuki, et al.
Published: (2010-02-01)

NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson’s disease
by: Li Cheng, et al.
Published: (2018-08-01)

Both Intracranial and Intravenous Administration of Functionalized Carbon Nanotubes Protect Dopaminergic Neuronal Death from 6-Hydroxydopamine
by: Kim OH, et al.
Published: (2020-10-01)

Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion.
by: David Reyes-Corona, et al.
Published: (2017-01-01)

Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
by: Tomás González-Hernández, et al.
Published: (2010-10-01)

Dopaminergic neurons show increased low-molecular-mass protein 7 activity induced by 6-hydroxydopamine in vitro and in vivo
by: Ming-Shu Mo, et al.
Published: (2018-08-01)

Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
by: Sandy Stayte, et al.
Published: (2015-01-01)

Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease
by: Richard Gordon, et al.
Published: (2016-09-01)

Baicalein Prevents 6-Hydroxydopamine-Induced Dopaminergic Dysfunction and Lipid Peroxidation in Mice
by: Heh-In Im, et al.
Published: (2005-01-01)

Suppression of 6-Hydroxydopamine-Induced Oxidative Stress by Hyperoside Via Activation of Nrf2/HO-1 Signaling in Dopaminergic Neurons
by: Seung-Hwan Kwon, et al.
Published: (2019-11-01)

Roles of FGF20 in dopaminergic neurons and Parkinson’s disease
by: Nobuyuki eItoh, et al.
Published: (2013-05-01)

Procyanidin protects against 6-hydroxydopamine-induced dopaminergic neuron damage via the regulation of the PI3K/Akt signalling pathway
by: Ying Zhang, et al.
Published: (2019-06-01)

Progesterone and the striatal 6-hydroxydopamine model of Parkinson’s disease
by: Perry, James Colin
Published: (2015)

Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson's disease.
by: Maho Kubota, et al.
Published: (2020-01-01)

Moxibustion Protects Dopaminergic Neurons in Parkinson’s Disease through Antiferroptosis
by: Zifeng Huang, et al.
Published: (2021-01-01)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
by: Zhimin Xu, et al.
Published: (2017-04-01)

Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.
by: Alisdair McNeill, et al.
Published: (2013-01-01)

Degeneration of dopaminergic neurons due to metabolic alterations and Parkinson’s disease
by: Juhyun eSong, et al.
Published: (2016-03-01)

Reconstruction of Dopaminergic neurons Metabolic Network with Application to Parkinson's Disease
by: Chao-Min Wang, et al.
Published: (2015)

Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson’s disease
by: Edward J. R. Fletcher, et al.
Published: (2019-12-01)

Phytic Acid Protects against 6-Hydroxydopamine-Induced Dopaminergic Neuron Apoptosis in Normal and Iron Excess Conditions in a Cell Culture Model
by: Qi Xu, et al.
Published: (2011-01-01)

Protective effects of treadmill exercise on hypobarichypoxia induced neuronal damage
by: Cheng-Jiun Wu, et al.
Published: (2009)

Behavioural analysis of 6-hydroxydopamine rodent models of Parkinson's disease
by: Heuer, Andreas
Published: (2012)

EFFECTS OF MH101 ON THE 6-HYDROXYDOPAMINE MODEL OF PARKINSON’S DISEASE
by: Po-Wen Ho, et al.
Published: (2010)

EFFECTS OF MAGNOLOL ON THE 6-HYDROXYDOPAMINE MODEL OF PARKINSON'S DISEASE
by: Siao-chin Lin, et al.
Published: (2008)

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease
by: Anna-Maija Penttinen, et al.
Published: (2018-06-01)